Stockreport

Hoth Therapeutics Announces $2.0 Million Registered Direct Offering [TheStreet.com]

Hoth Therapeutics, Inc.  (HOTH) 
PDF NEW YORK April 1, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for [Read more]